Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2005 3
2007 3
2008 2
2009 2
2010 1
2011 3
2012 2
2013 3
2014 4
2015 9
2016 8
2017 3
2018 6
2019 12
2020 7
2021 9
2022 6
2023 5
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

84 results

Results by year

Filters applied: . Clear all
Page 1
Assessment of hypoxia and oxidative-related changes in a lung-derived brain metastasis model by [64Cu][Cu(ATSM)] PET and proteomic studies.
Fantin J, Toutain J, Pérès EA, Bernay B, Mehani SM, Helaine C, Bourgeois M, Brunaud C, Chazalviel L, Pontin J, Corroyer-Dulmont A, Valable S, Cherel M, Bernaudin M. Fantin J, et al. Among authors: cherel m. EJNMMI Res. 2023 Nov 25;13(1):102. doi: 10.1186/s13550-023-01052-8. EJNMMI Res. 2023. PMID: 38006431 Free PMC article.
["New Modalities in Cancer Imaging and Therapy" XVth edition of the workshop organized by the network "Tumor Targeting, Imaging, Radiotherapies" of the Cancéropôle Grand-Ouest, 5-8 October 2022, France].
Léost F, Barbet J, Beyler M, Chérel M, Delpon G, Garcion E, Lacerda S, Lepareur N, Rbah-Vidal L, Vaugier L, Visvikis D. Léost F, et al. Among authors: cherel m. Bull Cancer. 2023 Dec;110(12):1322-1331. doi: 10.1016/j.bulcan.2023.08.007. Epub 2023 Oct 23. Bull Cancer. 2023. PMID: 37880044 Free article. Review. French.
Preclinical Evaluation of a 64Cu-Based Theranostic Approach in a Murine Model of Multiple Myeloma.
Métivier C, Le Saëc P, Gaschet J, Chauvet C, Marionneau-Lambot S, Hofgaard PO, Bogen B, Pineau J, Le Bris N, Tripier R, Alliot C, Haddad F, Chérel M, Chouin N, Faivre-Chauvet A, Rbah-Vidal L. Métivier C, et al. Among authors: cherel m. Pharmaceutics. 2023 Jun 25;15(7):1817. doi: 10.3390/pharmaceutics15071817. Pharmaceutics. 2023. PMID: 37514004 Free PMC article.
Immuno-PET: Design options and clinical proof-of-concept.
Lugat A, Bailly C, Chérel M, Rousseau C, Kraeber-Bodéré F, Bodet-Milin C, Bourgeois M. Lugat A, et al. Among authors: cherel m. Front Med (Lausanne). 2022 Oct 14;9:1026083. doi: 10.3389/fmed.2022.1026083. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36314010 Free PMC article. Review.
["Imaging of diagnostic and therapeutic biomarkers in oncology" XIIIth edition of the workshop organised by the « Vectorisation, Imagerie, Radiothérapies » network of the Cancéropôle Grand-Ouest, September 25-28, 2019, Le Bono, France].
Léost F, Chérel M, Chourpa I, Lacerda S, Vidal LR, Tripier R, Visvikis D. Léost F, et al. Among authors: cherel m. Bull Cancer. 2022 Oct;109(10):1094-1100. doi: 10.1016/j.bulcan.2022.05.010. Epub 2022 Aug 19. Bull Cancer. 2022. PMID: 35995612 French.
Molecular Signature of 18F-FDG PET Biomarkers in Newly Diagnosed Multiple Myeloma Patients: A Genome-Wide Transcriptome Analysis from the CASSIOPET Study.
Alberge JB, Kraeber-Bodéré F, Jamet B, Touzeau C, Caillon H, Wuilleme S, Béné MC, Kampfenkel T, Sonneveld P, van Duin M, Avet-Loiseau H, Corre J, Magrangeas F, Carlier T, Bodet-Milin C, Chérel M, Moreau P, Minvielle S, Bailly C. Alberge JB, et al. Among authors: cherel m. J Nucl Med. 2022 Jul;63(7):1008-1013. doi: 10.2967/jnumed.121.262884. Epub 2022 Jan 27. J Nucl Med. 2022. PMID: 35086897 Free PMC article.
84 results